52612-54-1

Basic information

• Product Name: (+)-(R)-3-(2,6,6-Trimethyl-2-cyclohexen-1-yl)-(E)-propensaeure
• Synonyms: (+)-(R)-3-(2,6,6-Trimethyl-2-cyclohexen-1-yl)-(E)-propensaeure
• CAS NO: 52612-54-1
• Molecular Weight: 194.274
• Mol File: 52612-54-1.mol

Chemical Properties

• CAS DataBase Reference: (+)-(R)-3-(2,6,6-Trimethyl-2-cyclohexen-1-yl)-(E)-propensaeure(CAS DataBase Reference)
• NIST Chemistry Reference: (+)-(R)-3-(2,6,6-Trimethyl-2-cyclohexen-1-yl)-(E)-propensaeure(52612-54-1)
• EPA Substance Registry System: (+)-(R)-3-(2,6,6-Trimethyl-2-cyclohexen-1-yl)-(E)-propensaeure(52612-54-1)

Safety Data

• Hazardous Substances Data: 52612-54-1(Hazardous Substances Data)

Upstream product

• 127-41-3 alpha-ionone 
• 37384-69-3 3-(2,6,6-trimethyl-2-cyclohexen-1-yl)-2-propenoic acid 
• 24190-29-2 (R)-α-ionone 

Downstream Products

• 52567-55-2 3-((R)-2,6,6-Trimethyl-cyclohex-2-enyl)-propionic acid methyl ester 
• 52567-60-9 3-((R)-2,2-Dimethyl-6-methylene-cyclohexyl)-propan-1-ol 
• 52567-59-6 3-((S)-2,2-Dimethyl-6-methylene-cyclohexyl)-propan-1-ol 
• 52567-56-3 (-)-α-Cyclogeranylethanol 
• 52612-55-2 (1R,2R)-2-(3-Hydroxy-propyl)-1,3,3-trimethyl-cyclohexanol 
• 83059-15-8 (2E)-3-[(1R)-2,6,6-trimethyl-2-cyclohexen-1-yl]acrylaldehyde 
• 83021-18-5 (+)-(R)-9-(2,6,6-Trimethyl-2-cyclohexen-1-yl)-(all-E)-2,4,6,8-nonatetraensaeureaethylester 
• 83021-19-6 (+)-(R)-9-(2,6,6-Trimethyl-2-cyclohexen-1-yl)-(all-E)-2,4,6,8-nonatetraen-1-ol 
• 83021-20-9 (+)-(R)-9-(2,6,6-Trimethyl-2-cyclohexen-1-yl)-(all-E)-2,4,6,8-nonatetraenal 
• 83059-14-7 (+)-(R)-3-(2,6,6-Trimethyl-2-cyclohexen-1-yl)-(E)-propenol 
• 52567-54-1 (E)-3-((R)-2,6,6-Trimethyl-cyclohex-2-enyl)-acrylic acid methyl ester 

Relevant articles and documents

Discovery of Antimetastatic Chiral Ionone Alkaloid Derivatives Targeting HIF-1α/VEGF/VEGFR2 Pathway

Novel chiral ionone alkaloid derivatives were synthesized and their antimetastatic effects were evaluated in human breast cancer cells using chemotaxis assay. Compared with positive control LY294002, a PI3 K inhibitor, derivatives 10 a, 11 a, 11 c, 11 g,

Synthesis and anti-metastatic effects of novel chiral ionone alkaloid derivatives

Abstract Novel chiral ionone alkaloid derivatives were synthesized and evaluated their anti-metastatic effects in human MDA-MB-231 breast cancer cells. The chiral center C-6 of derivatives exerted an important role in response to the anti-metastatic activ